These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17312166)

  • 1. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes.
    van Montfort T; Nabatov AA; Geijtenbeek TB; Pollakis G; Paxton WA
    J Immunol; 2007 Mar; 178(5):3177-85. PubMed ID: 17312166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.
    Nabatov AA; van Montfort T; Geijtenbeek TB; Pollakis G; Paxton WA
    FEBS J; 2006 Nov; 273(21):4944-58. PubMed ID: 17010165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.
    Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H
    Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
    Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D
    Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.
    Wang JH; Janas AM; Olson WJ; KewalRamani VN; Wu L
    J Virol; 2007 Mar; 81(5):2497-507. PubMed ID: 17151103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.
    Granelli-Piperno A; Pritsker A; Pack M; Shimeliovich I; Arrighi JF; Park CG; Trumpfheller C; Piguet V; Moran TM; Steinman RM
    J Immunol; 2005 Oct; 175(7):4265-73. PubMed ID: 16177066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
    Lekkerkerker AN; Ludwig IS; van Vliet SJ; van Kooyk Y; Geijtenbeek TB
    Virology; 2004 Nov; 329(2):465-76. PubMed ID: 15518824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.
    Yu Kimata MT; Cella M; Biggins JE; Rorex C; White R; Hicks S; Wilson JM; Patel PG; Allan JS; Colonna M; Kimata JT
    J Virol; 2002 Dec; 76(23):11827-36. PubMed ID: 12414925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
    J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody.
    van Montfort T; Thomas AA; Krawczyk PM; Berkhout B; Sanders RW; Paxton WA
    J Immunol; 2015 Oct; 195(8):3759-68. PubMed ID: 26355155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN.
    Sabatté J; Ceballos A; Raiden S; Vermeulen M; Nahmod K; Maggini J; Salamone G; Salomón H; Amigorena S; Geffner J
    J Virol; 2007 Dec; 81(24):13723-34. PubMed ID: 17913809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
    Naarding MA; Ludwig IS; Groot F; Berkhout B; Geijtenbeek TB; Pollakis G; Paxton WA
    J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissue.
    Canard B; Vachon H; Fontaine T; Pin JJ; Paul S; Genin C; Mueller CG
    Immunol Lett; 2011 Mar; 135(1-2):165-72. PubMed ID: 21078343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.
    van Montfort T; Thomas AA; Pollakis G; Paxton WA
    J Virol; 2008 Aug; 82(16):7886-96. PubMed ID: 18524826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN.
    Lee SJ; Arora R; Bull LM; Arduino RC; Garza L; Allan J; Kimata JT; Zhou P
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):874-83. PubMed ID: 16989613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
    Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
    J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.
    Binley JM; Ngo-Abdalla S; Moore P; Bobardt M; Chatterji U; Gallay P; Burton DR; Wilson IA; Elder JH; de Parseval A
    Retrovirology; 2006 Jul; 3():39. PubMed ID: 16817962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.